GlycoMimetics, Inc. (GLYC)

USD 0.22

(-4.8%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 10 Thousand 74.92 Thousand 1.16 Million 10.16 Million - -
Cost of Revenue 153.3 Thousand 1.03 Million 1.01 Million - 899.3 Thousand 275.12 Thousand
Gross Profit -143.3 Thousand -957.23 Thousand 146.36 Thousand 10.16 Million -899.3 Thousand -275.12 Thousand
Operating Expenses 39.28 Million 47.47 Million 64.6 Million 61.67 Million 61.38 Million 51.5 Million
Selling, General and Administrative Expenses 19.21 Million 19.08 Million 17.11 Million 16.74 Million 14.36 Million 11.41 Million
Research and Development Expenses 20.07 Million 28.39 Million 47.49 Million 44.92 Million 47.02 Million 40.09 Million
Other Expenses - - - - - 3.23 Million
Cost and Expenses 39.28 Million 47.47 Million 64.6 Million 61.67 Million 61.38 Million 51.5 Million
Operating Income -39.27 Million -47.4 Million -63.44 Million -51.5 Million -61.38 Million -51.5 Million
Interest Expense - 46.64 Million - - - -
Income Tax Expense -637.00 46.64 Million -284.6 Thousand -752.75 Thousand -3.77 Million 3.23 Million
Earnings before Tax -36.89 Million -46.68 Million -63.42 Million -51.02 Million -57.89 Million -48.27 Million
Net Income -36.89 Million -93.32 Million -63.14 Million -50.27 Million -54.11 Million -48.27 Million
Earnings Per Share Basic -0.58 -1.78 -1.23 -1.10 -1.25 -1.18
Earnings Per Share Diluted -0.58 -1.78 -1.23 -1.10 -1.25 -1.18
Weighted Average Shares Outstanding 63.34 Million 52.53 Million 51.45 Million 45.72 Million 43.25 Million 41.04 Million
Weighted Average Shares Outstanding (Diluted) 63.34 Million 52.53 Million 51.45 Million 45.72 Million 43.25 Million 41.04 Million
Gross Margin -14.33 -12.78 0.13 1.00 - -
EBIT Margin -3912.20 -632.67 -54.70 -5.07 - -
Profit Margin -3689.94 -1245.63 -54.43 -4.95 - -
EBITDA -39.12 Million -47.19 Million -63.18 Million -51.23 Million -56.99 Million -51.22 Million
Earnings Before Tax Margin -3927.53 -632.67 -54.70 -5.07 - -

Income Statement Charts